Based on recent data, Centessa Pharmaceuticals plc (CNTA) shows an Average True Range (ATR) of 1.23 and an Enterprise Value of 890.97M. Its average trading volume over the past 3 months is 2.62M, indicating liquidity. These fundamental metrics provide insight into CNTA's underlying financial health and market activity.
| ATR | 1.23 |
| Enterprise Value | 890.97M |
| Avg Vol (3 Months) | 2.62M |
| Avg Vol (10 Days) | 1.66M |
Centessa Pharmaceuticals plc (CNTA) technical indicators as of June 11, 2026: the SMA 20 is 7.74%, SMA 50 at 9.7%, and SMA 200 at 30.29%. The RSI 14 value is 65.54, suggesting its current momentum. These technical analysis signals help assess CNTA's price trends and potential future movements.
| SMA 20 | 7.74% |
| SMA 50 | 9.7% |
| SMA 200 | 30.29% |
| RSI 14 | 65.54 |
Centessa Pharmaceuticals plc (CNTA) stock performance overview as of June 11, 2026: The 52-week high is $40.26 (currently -12.46% below), and the 52-week low is $11.77 (currently 178.85% above). Over the past year, CNTA's performance is 54.14%, compared to the S&P 500's 9.37% change.
| 52-Week High | 40.26 |
| 52-Week High Chg | -12.46% |
| 52-Week Low | 11.77 |
| 52-Week Low Chg | +178.85% |
| S&P 500 52-Week Chg | 9.37% |
According to market data, Centessa Pharmaceuticals plc (CNTA) stock's recent performance metrics show that over the last month, CNTA is -8.25%, with a Year-to-Date (YTD) performance of -8.36%. Over the past year, the stock has seen a 54.14% change. These figures summarize CNTA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 39.88 | 39.92 | 40.26 | 40.26 | 40.26 | 40.26 |
| Low | 39.58 | 39.53 | 25.06 | 21.5 | 11.77 | 21.5 |
| Performance | +4.09% | -8.25% | -0.43% | +42.71% | +54.14% | -8.36% |
According to current financial data, CNTA stock's P/E (TTM) ratio is -24.30, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CNTA, including P/S (N/A), P/B (12.50), and P/FCF (-29.34), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CNTA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -24.3 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 12.5 | 1.15 | 10.92 | 5.27 |
| P/FCF (TTM) | -29.34 | -6.79 | -912.14 | 29.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep